Clinical trial
Impact of Rosuvastatin on Endothelial Function and Inflammation in Patients With…
NCT00176332 · University of Leipzig, Other · Completed
Key facts
| NCT number | NCT00176332 |
|---|---|
| Title | Impact of Rosuvastatin on Endothelial Function and Inflammation in Patients With Chronic Heart Failure |
| Official title | Impact of Three Months of Rosuvastatin Treatment on Peripheral Endothelial Function, Inflammatory Markers in the Blood and the Skeletal Muscle and on Postnatal Vasculogenesis in Patients With Severe Chronic Heart Failure |
| Lead sponsor | University of Leipzig, Other |
| Collaborators | AstraZeneca Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Heart Failure |
| Intervention type | Drug |
| Interventions | rosuvastatin |
| Enrollment | 40 |
| Start date | Mar 1, 2004 |
| Completion | Dec 1, 2006 |
| First posted | Sep 15, 2005 |
| Last update posted | Aug 1, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: